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Aim. To investigate reactive changes of GFAP-positive astrocytes as a marker of brain response 
following hemorrhagic stroke and HSV-I. Methods. The experiments were performed on 110 
Balb/c mice weighing 18–20 g. The animals were infected with HSV type I, on 30 day hem-
orrhagic stroke was simulated and changes in astrocytes were determined by immunohisto-
chemistry. Gliosis was confirmed by changes in density and arborization of GFAP-positive 
astrocytes. Results. The results of immunohistochemical studies confirmed increased density 
of GFAP-positive astrocytes in the hippocampus of mice infected with HSV type I as well as 
the sharp increase in the density and hypertrophy of GFAP-positive astrocytes following stroke 
simulation in infected animals. Conclusions. The experiment has provided new evidence about 
the location and level of astrocytic gliosis following a stroke and herpes infection. GFAP can 
be studied as a marker of HSV type I reactivation against stroke. 
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Introduction
Glial fibrillary acidic protein (GFAP) is a basic 
intermediate filament of astrocytes [1]. In the 
intact brain astrocytes carry out such functions 
as trophic, formation of the blood-brain bar-
rier and neurotransmitters metabolism. The 
GFAP expression in the intact astrocytes takes 
place constantly. In addition GFAP-knockout 
mice usually suffer for multiple degenerative 
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processes, for example, abnormal myelination 
of the brain’s white matter and violation of the 
blood-brain barrier [2].
As a consequences of brain damage the 
astrocytes hypertrophy, increase in appendages 
length, raise of GFAP expression and density 
of GFAP-positive cells occur into the lesion 
site. These morphological and biochemical 
changes were called an astrocytic gliosis, or 
astrogliosis [3]. The astrogliosis manifests 
through the glial scars formation which results 
in separation the affected area from the intact 
brain tissue. Although the astrocytic gliosis is 
considered as structural manifestation of nerve 
system pathological changes there are conclu-
sive evidence that gliosis is typical protective 
reaction of the central nerve system which 
forms against the different types of damage. 
The astrocytes restrict the foci of inflammation 
and necrosis, recover the blood-brain barrier 
and synthesize the cytokines [4]. The last re-
search indicated that astrocytes take part in the 
implementation of proinflammatory immune 
reactions as well as in the anti-inflammatory 
protective function. All the changes develop as 
proliferation and migration of astrocytes while 
on the cytology level as raise of GFAP expres-
sion and increase in appendages length of 
GFAP-positive astrocytes. Pay attention to the 
changes of GFAP expression we can forecast 
the nature of brain structural changes. In this 
case the decrease of GRFAP-positive cells 
should be the manifestation of necrosis or 
apoptosis of gliocytes while the increase of 
GFAP-positive cells shows the reactive chan-
ges, regeneration or metabolic restructuring [5].
Exploring the reactive changes in the brain 
by GFAP expression allows us to learn the 
patterns of brain injury and recovery. One of 
the current interest is a study of the cerebro-
vascular accident and inflammation because 
the stroke isn’t limited by the ischemic brain 
damage but can be described with development 
of inflammation and neurodegeneration [6, 7]. 
During a long time neurodegenerative chan ges 
were examined as focal or diffuse neuronal 
death. Nowadays we don’t divide the neural 
and glial pathology but evaluate it as a sys-
temic histopathological process [8].
In the previous study we have reported the 
dependence of neurodegeneration in mice’s 
brains on human simplex virus (HSV-1) reac-
tivation after stroke modeling. In the hippo-
campus of infected animals the number of dead 
neurons correlated with the quantitative indica-
tors HSV-1 in the brain samples in vitro (PCR, 
IFA, cell culture Vero). Nevertheless the astro-
cytes role and methods of reactive changes 
determining didn’t investigate. In this work we 
have determined the gliosis by GFAP-positive 
astrocytes level in the brain of HSV-1-infected 
mice.
The goal of our work was to investigate the 
GFAP-positive astrocytes changes as the man-
ifestation of their reactive changes in response 
to brain damage with hemorrhagic stroke and 
HSV-1-infection.
Table 1. Groups of animals
Group Quantity
Group 1 – HSV-1 infected mice 15
Group 2 – mice with hemorrhagic stroke 15
Group 3 – HSV-1 infected mice with 
hemorrhagic stroke
40
Control group 1 – intact mice 10
Control group 2 – control to the group 1 10
Control group 3 – control to the group 2 10
Control group 4 – control to the group 3 10
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Materials and Methods
The experiments were held on the 110 white 
mice Balb/c with a weight of 18–20 gm. All 
animals were divided into 7 groups (Table 1).
The technique of infecting (group 1) was 
based on the epidural 0,03 ml of virus-contai-
ning material (LD50) injection into the orphan 
site. We used the lyophilized HSV-1 (strain 
VC). This model renders a meningoencepha-
litis in 100 %. The symptoms of infectious 
process are usually noted on the 5th–6th day, 
peak on the 13th–14th day, after that decrease 
and animals recover. As a result the HSV-1 
infection turns to the latent form.
The intracerebral hemorrhage (ICH) 
(group 2) was accomplished by 0,15–0,2 ml 
of autoblood injection into the brain’s right 
hemisphere (L = 1,5; H = 3,0; AP = –1,0 mm 
from Bregma) (Fig. 1). The manipulation was 
run due to the stereotactic atlas [11]. According 
to this mo del the ICH and neurological disor-
ders formed in animals. The hemorrhage local-
ized in the capsula interna, CI. On the day 30 
after HSV-infection animals from group 3 
Fig. 1. There is a scheme of the autoblood injection into the mouse brain. The right capsula interna site is pointed.
418
A. V. Gumenyuk, S. L. Rybalko, S. I. Savosko et al.
(weakness, sedentary, decrease in appetite) 
were modeled the ICH.
The control animals were divided into 
4 groups for 10 mice. Control group 1 was the 
intact animals. Control group 2 was the ani-
mals injected with the 0,03 ml of saline into 
the orphan site. Control group 3 was the mice 
operated with a needle into the brain’s right 
hemisphere (L = 1,5; H = 3,0; AP = –1,0 mm 
from Bregma) without autoblood injection. 
Control group 4 was the mice injected with the 
0,03 ml of saline into the orphan site and then 
operated with a needle into the brain’s right 
hemisphere (L = 1,5; H = 3,0; AP = –1,0 mm 
from Bregma) without autoblood injection on 
the day 30 after HSV-infection.
The animals were removed from the ex-
periment on the day 40 in the group 1 and on 
the day 10 after stroke modeling. For immu-
nohistochemical analysis the mice’ brains were 
fixed in the paraformaldehyde solution, washed 
with the saline, conducted in the ethyl alcohol 
increasing concentrations and perfused in the 
Leica Surgipath Paraplast Regular. The frontal 
6 microns thick sections were gotten using a 
Thermo Microm HM 360 microtome.
These sections were deparafinized in the 
xylene and ethyl alcohol increasing concentra-
tions, air-dried and washed with the buffered 
saline (PBS). Then the sections were blocked 
into the 3 % bovine serum albumin solution 
(BSA) in the PBS with 0,05 % Triton X-100 
(PBST) during 60 minutes at room tempera-
ture. After that the sections were incubated 
with the antibodies against GFAP (rabbit anti-
GFAP antibodies, sc-9065, Santa Cruz Bio-
tech nology, USA) in the 1:200 dilution in 
PBST during 18 hours at +4 °С. Anti-GFAP 
antibody was a kind gift of Prof. V.S. 
Nedzvetsky (Dnipro National University, 
Ukraine). The sections were subsequently 
washed for 3 times and then incubated with 
the secondary antibodies conjugated with a 
fluorescein isothiocyanate (FITC) in the 1:500 
dilution in PBST during 60 minutes at room 
temperature. In order to visualize the cells’ 
nuclei the sections were washed again and 
treated with a Hoechst-33342 fluorescent dye 
(1 mcg/ml). The results of the immunofluores-
cent staining were gotten with a Carl Zeiss 
LSM 510 microscope (Carl Zeiss, Germany) 
and processed in the Zeiss ZEN software. In 
addition we have used the toluidine blue stain-
ing to identify the cells composition and the 
inflammation and neurodegeneration foci in 
the all brains samples.
For the quantitative assessment of the GFAP-
positive astrocytes changes we have carried out 
a morphometric examination. The number of 
astrocytes in the 0,25 mm of the test area and 
cells perimeter were measured. The perimeter 
was determined using the contours of the visible 
GFAP-positive binding profile (body and ap-
pendages of the astrocytes).
All the experimental procedures comply 
with the international ethical standards such 
as “Regulations on the animal use of in re-
search biomedical research”, “European 
Convention for the protection of vertebrate 
animals used for experimental and other sci-
entific purposes”, “Guide for the Care and Use 
of Laboratory Animals” and the standards of 
Commission on bioethics of Bogomolets 
National Medical University.
Results and Discussion
The results of mice’ brains immunohistochem-
ical analysis detected a significant increase of 
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specific antibodies to GFAP binding in the 
HSV-infected animals. In the hemorrhagic 
stroke and virus infection conditions a synthe-
sis level was more expressed (Fig. 2).
It should be noted that we have not disco-
vered the significant difference between the 
astrocytes staining intensity of control groups. 
In the groups 1–4 the specific immunostaining 
was found only round the nuclei while in the 
pathology conditions the dense GFAP-positive 
binding was found in the cells’ bodies as well 
as in the numerous appendages what indicated 
the astrocytes hypertrophy. We often marked 
the specific antibodies to GFAP binding around 
the microvessels as the astrocytes appendages 
located around the hemocapillaries. These find-
ings make us sure about reactive gliosis man-
ifestation in the infection condition.
The topography and glial reaction analysis 
showed the dominant development of local 
astrogliosis in the perifocal zone (CA1 and CA3 
hippocampus sites) or diffuse gliosis in all hip-
pocampus sites, corpus callosum and deep lay-
ers of ipsilateral hemisphere neocortex.
The progressive gliosis was detected 
through the quantitative density of GFAP-
positive astrocytes determination in the ipsi-
lateral cerebral cortex and CA1 hippocampus 
site (Fig 3, 4). We have not discovered the 
statistically significant difference between the 
astrocytes quantitative indicators in the control 
groups. Therefore we used data from the intact 
mice to make the figures and data from all 
control groups of animals for comparison. The 
significant density increase of astrocytes in the 
CA1 hippocampus site was found in the 
1 
3 
2 
4 
Fig. 2. The immunohistochemical 
analysis of mice’ brains frontal sec-
tions in the hemorrhagic stroke, 
HSV-1 and hemorrhagic stroke with 
HSV-infection conditions. Specific 
antibodies to GFAP binding; the nu-
clei colored with Hoechst-33342 
fluorescent dye, confocal microsco-
py. 1 – СА1 hippocampus site of the 
intact mice; 2 – СА1 hippocampus 
site of the mice with hemorrhagic 
stroke; 3 – СА1 hippocampus site of 
the HSV-infected mice; 4 – СА1 hip-
pocampus site of the HSV-infected 
mice with hemorrhagic stroke.
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group 3. This index after stroke modeling sta-
tistically significant rose approximately 
2,8 times.
There are results of the morphometric anal-
ysis on the Fig. 5 and 6 which show the sta-
tistically significant increase of GFAP-positive 
astrocytes perimeter (with the appendages 
considered) in the HSV-infected animals 
(groups 1, 3)
The variability of astrogliosis development 
may be connected with the infectious process 
level and brain ischemia size. But a brain ede-
ma as the main histostructural agent of brain 
damage progresses into the hemorrhage site as 
well as into the contralateral hemisphere. This 
process mainly occurs through the corpus cal-
losum. However the astrocytes reactive chan-
ges were only discovered in the brain’s ipsi-
lateral hemisphere what represents the astro-
cytes answer to the herpetic neuroinfection.
As we know, GFAP is a specific protein of 
astrocytes’ intermediate filaments. This protein 
Fig. 4. There is GFAP-positive astrocytes density in the 
СА1 hippocampus site of ipsilateral hemisphere. Note: 
* – significantly compared to the control (р<0,05); # – 
significantly compared to the group 1 (р<0,05); ^ – sig-
nificantly compared to the group 2 (р<0,05).
Fig. 3. There is GFAP-positive astrocytes density in the 
cortex. Note: * – significantly compared to the control 
(p<0,05).
Fig. 5. There is GFAP-positive astrocytes perimeter in 
the cortex. Note: * – significantly compared to the con-
trol (р < 0,05); # – significantly compared to the group 1 
(р < 0,05).
Fig. 6. There is GFAP-positive astrocytes perimeter in 
the СА1 hippocampus site of ipsilateral hemisphere. 
Note: * – significantly compared to the control (р < 0,05); 
# – significantly compared to the group 1 (р < 0,05); ^ – 
significantly compared to the group 2 (р < 0,05).
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provides the structure and sturdiness of intact 
astrocytes’ cytoskeleton but in the brain injury 
condition the GFAP expression can increase 
abruptly. This index can vary dramatically in 
some pathological conditions, for example, 
cerebral trauma [12], stroke [13], Alzheimer’s 
disease [14] and Parkinson’s disease [15]. The 
synthesis of GFAP is activated by numerous 
growth factors such as ciliary neurotrophic 
factor (CNTF) [16], fibroblast growth factor 
(FGF), transforming growth factor β (TGF-β) 
[17] and interleukins [18].
The relationship between astrocytes reactions 
and neuroinfection was performed only in a few 
studies. Nowadays we have not any data or 
methodical approaches (cytological, histologi-
cal) for primary herpetic infection localization 
detection in the CNS. It is considered that the 
latent infection localizes into the ganglions’ 
neurons but at the same time the virus was 
detected in the brain’s stem [19]. The cortex 
damage was discovered after virus injection into 
the facial nerve [20]. In these studies the neu-
rons apoptosis is examined as the main path of 
neurodegeneration in HSV-infection condition. 
Nevertheless, the vascular and glial factors are 
focused on too. In particular the astrocytes and 
macrophages activation into the brain in her-
petic encephalitis condition and gliosis develop-
ment were showed through the immunocyto-
chemical method [21].
In our study an increase in the number of 
GFAP-positive astrocytes appendages around 
the blood vessels may be determined by mi-
crovessels participation in the inflammatory 
process. We can assume that the astrocytes take 
part in the blood-brain barrier recover as well 
as in the intercellular interaction with immu-
nocompetent cells.
In this way the data we have received through 
our investigation point out the role of the GFAP-
positive astrocytes in the herpetic infection 
development and reactivation after stroke. The 
further research about the glial cells participa-
tion in the neurodegeneration process is impor-
tant in order to understand the general character 
of brain damage development.
Conclusions
In the HSV-1-infection condition the increase 
of GFAP-positive astrocytes takes place (into 
the hippocampus mainly) as well as after 
stroke modeling but the last one is also char-
acterized by increased GFAP expression. The 
perifocal localization of astrocytic gliosis ex-
plains the brain structural changes after stroke 
and virus reactivation. GFAP is considered to 
be a marker for HSV-reactivation in the stroke 
condition.
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GFAP як показник реактивних змін астроцитів у 
мозку мишей з геморагічним інсультом та ВПГ-І 
A. В. Гуменюк, С. Л. Рибалко, С. І. Савосько, 
М. М. Гузик, А. О. Тихомиров, А. О. Рижа, 
Ю. Б. Чайковський 
Мета. Дослідити зміни GFAP-позитивних астроцитів 
як прояв їх реактивних змін у відповідь на пошкоджен-
ня мозку при геморагічному інсульті та ВПГ-І. Методи. 
Проведено експерименти на 110 білих мишах Balb/c 
масою 18–20 г. Тварин інфікували ВПГ-І, на 30 добу 
моделювали геморагічний інсульт і визначали зміни 
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астроцитів методом імуногістохімії. Гліоз визначали 
за щільністю та арборизацією відростків GFAP-
позитивних астроцитів. Результати. Результати іму-
ногістохімічного дослідження засвідчили збільшення 
щільності GFAP-позитивних відростків астроцитів у 
гіпокампу мишей інфікованих ВПГ-І, а після моделю-
вання інсульту у інфікованих тварин різке збільшення 
щільності і гіпертрофію GFAP-позитивних астроцитів. 
Висновки. В експерименті отримано нові дані щодо 
локалізації та рівня астроцитарного гліозу при інсуль-
ті та герпетичній інфекції. GFAP можна розглядати як 
маркер реактивації ВПГ-І на тлі інсульту.
К л юч ов і  с л ов а: GFAP, астроцити, ВПГ-І, інсульт 
GFAP как показатель реактивных изменений 
астроцитов в мозге мышей с геморрагическим 
инсультом и ВПГ-I
A. В. Гуменюк, С. Л. Рыбалко, С. И. Савосько, 
М. М. Гузик, А. А. Тихомиров, А. А. Рыжая, 
Ю. Б. Чайковский
Цель. исследовать изменения GFAP-позитивных 
астроцитов как проявление их реактивных изменений 
в ответ на повреждение мозга при геморрагическом 
инсульте и ВПГ-I. Методы. Проведены эксперименты 
на 110 белых мышах Balb/c массой 18–20 г. Животных 
инфицировали ВПГ-I, на 30 сутки моделировали ге-
моррагический инсульт и определяли изменения астро-
цитов методом иммуногистохимии. Глиоз определяли 
по плотности и арборизации отростков GFAP-
позитивных астроцитов. Результаты. Результаты им-
муногистохимического исследования показали увели-
чение плотности GFAP-позитивных отростков астро-
цитов в гиппокампе мышей инфицированных ВПГ-I, 
а после моделирования инсульта у инфицированных 
животных резкое увеличение плотности и гипертро-
фию GFAP-позитивных астроцитов. Выводы. В экс-
перименте получены новые данные по локализации и 
уровню астроцитарного глиоза при инсульте и герпе-
тической инфекции. GFAP можно рассматривать как 
маркер реактивации ВПГ-I на фоне инсульта.
К л юч е в ы е  с л ов а: GFAP, астроциты, ВПГ-I, ин-
сульт
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